Stifel Financial
ABMD

Stifel Financial’s Abiomed Inc ABMD Stock Holding History

Stifel Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-637
Closed -$211K – 3494
2022
Q1 		$211K Buy
637
+7
+1% +$2.15K ﹤0.01% 3097
2021
Q4 		$226K Sell
630
-308
-33% -$104K ﹤0.01% 3085
2021
Q3 		$305K Sell
938
-137
-13% -$46.4K ﹤0.01% 2895
2021
Q2 		$336K Sell
1,075
-171
-14% -$52.5K ﹤0.01% 2826
2021
Q1 		$397K Sell
1,246
-235
-16% -$75.2K ﹤0.01% 2623
2020
Q4 		$481K Buy
1,481
+246
+20% +$68K ﹤0.01% 2341
2020
Q3 		$342K Buy
1,235
+225
+22% +$64.8K ﹤0.01% 2314
2020
Q2 		$244K Buy
+1,010
New +$203K ﹤0.01% 2490
2020
Q1 		– Sell
-1,785
Closed -$308K – 3150
2019
Q4 		$308K Sell
1,785
-923
-34% -$171K ﹤0.01% 2522
2019
Q3 		$486K Sell
2,708
-1,576
-37% -$341K ﹤0.01% 2187
2019
Q2 		$1.12M Sell
4,284
-3,590
-46% -$953K ﹤0.01% 1727
2019
Q1 		$2.25M Buy
7,874
+2,895
+58% +$962K 0.01% 1174
2018
Q4 		$1.62M Buy
4,979
+363
+8% +$126K 0.01% 1262
2018
Q3 		$2.07M Buy
4,616
+2,603
+129% +$1.03M 0.01% 1247
2018
Q2 		$819K Sell
2,013
-71
-3% -$25.7K ﹤0.01% 1756
2018
Q1 		$605K Sell
2,084
-862
-29% -$218K ﹤0.01% 1855
2017
Q4 		$548K Sell
2,946
-81
-3% -$15.1K ﹤0.01% 1863
2017
Q3 		$509K Sell
3,027
-553
-15% -$83.6K ﹤0.01% 1876
2017
Q2 		$509K Sell
3,580
-338
-9% -$45.4K ﹤0.01% 1864
2017
Q1 		$496K Buy
3,918
+163
+4% +$18.9K ﹤0.01% 1818
2016
Q4 		$424K Buy
3,755
+127
+4% +$14.7K ﹤0.01% 1867
2016
Q3 		$466K Buy
+3,628
New +$435K ﹤0.01% 1762
2016
Q2 		– Sell
-2,611
Closed -$248K – 2582
2016
Q1 		$248K Buy
+2,611
New +$220K ﹤0.01% 1913

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stifel Financial's ABMD Position: Q2 2022 in Review

Stifel Financial sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 637 shares — an estimated $211K sold.

Stifel Financial first reported a position in ABMD in Q1 2016 and held it in 23 quarters. The position peaked at $2.25M in Q1 2019. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Stifel Financial reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Stifel Financial sold 637 Abiomed Inc shares in Q2 2022, an estimated $211K.
  • Stifel Financial first reported a position in Abiomed Inc in Q1 2016 and held it in 23 quarters.
  • Stifel Financial's Abiomed Inc position peaked at $2.25M in Q1 2019.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Stifel Financial's 13F filing for Q2 2022, filed 15 Aug 2022.